Zevra Therapeutics Announces Positive Final Results from Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia at SLEEP 2024 Annual Meeting KP1077 was well tolerated and showed meaningful clinical improvements in patient-reported assessments of daytime sleepiness, sleep inertia, and brain fog Additional data presented on...

VelocityEHS Double Winner in Occupational Health & Safety 2021 Industrial Hygiene Awards CHICAGO, April 15, 2021 (GLOBE NEWSWIRE) -- VelocityEHS, the global leader in cloud-based environment, health, safety (EHS) and sustainability software, announced it has won Platinum Awards in two...